Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14717 | 4 | 0.09 | Mlig455_052787 | Neo: - Age: - |
Mlig455_052787 {REF} {Length: 355} {RNA1509_43735} {RNA1310_16914} {RNA815_17245} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14717 | 4 | 0.09 | Mlig455_052787 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_052787 {REF} {Length: 355} {RNA1509_43735} {RNA1310_16914} {RNA815_17245} | |
2. | MligTC455_37668 | 16 | 0.32 | Mlig455_056257 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_056257 {REF} {Length: 2106} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.7]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=86.7, Expect=6e-18]} {RNA1509_42704} {RNA1310_21353.2} {RNA815_9313} | |
3. | MligTC455_00615 | 4 | 0.09 | Mlig455_044144 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_044144 {REF} {Length: 198} {TRANSSPLICED} {NoTransDecoderORF} | |
4. | MligTC455_56624 | 8 | 0.17 | Mlig455_034946 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_034946 {REF} {Length: 329} {NoTransDecoderORF} {RNA1310_78916} {RNA815_63138} | |
5. | MligTC455_22408 | 69 | 1.43 | Mlig455_020360 | Neo: Int S/G2/M Age: Down-Up-Down |
MAN1B1 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_020360 {REF} {Length: 3567} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=516.9]} {Human: ENSG00000177239, MAN1B1, mannosidase alpha class 1B member 1, [RH, Score=509, Expect=2e-173]} {Mouse: ENSMUSG00000036646, Man1b1, mannosidase, alpha, class 1B, member 1, [RH, Score=522, Expect=3e-179]} {Dmel: FBgn0039634, alpha-Man-Ib, alpha-Mannosidase class I b, [RH, Score=479, Expect=2e-162]} {Celegans: WBGene00020197, mans-3, alpha-1,2-Mannosidase, [RH, Score=454, Expect=3e-154]} {Smed: dd_Smed_v6_7032_0_1, dd_Smed_v6_7032_0_1, [RH, Score=514, Expect=3e-178]} {RNA1509_10584} {RNA1310_11173, RNA1509_10584} {RNA1509_10584, RNA815_9464} |
6. | MligTC455_11133 | 24 | 0.5 | Mlig455_036188 | Neo: Int S/G2/M Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_036188 {REF} {Length: 1185} {NoTransDecoderORF} {RNA1509_60021} {RNA1310_108053} {RNA815_10011.1} | |
7. | MligTC455_07305 | 45 | 0.94 | Mlig455_022055 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_022055 {REF} {Length: 1195} {Mouse: ENSMUSG00000033088, Triobp, TRIO and F-actin binding protein, [Score=51.6, Expect=4e-07]} {Smed: dd_Smed_v6_1985_0_1, dd_Smed_v6_1985_0_1, [Score=53.1, Expect=5e-08]} | |
8. | MligTC455_06500 | 15 | 0.31 | Mlig455_025797 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_025797 {REF} {Length: 1697} {NoTransDecoderORF} {RNA1509_54874} {RNA1310_106012} | |
9. | MligTC455_05646 | 6 | 0.13 | Mlig455_013878 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_013878 {REF} {Length: 366} {NoTransDecoderORF} {RNA1509_33205} {RNA1310_69080} {RNA815_19175.1} | |
10. | MligTC455_11142 | 10 | 0.2 | Mlig455_041921 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_041921 {REF} {Length: 2053} {NoTransDecoderORF} {RNA1310_33225.1} {RNA815_38499} | |
11. | MligTC455_18624 | 4 | 0.09 | Mlig455_018330 | Neo: - Age: Down-Up-Down |
SPATS1 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_018330 {REF} {Length: 1361} {TRANSSPLICED} {Pfam: Spermatogenesis-associated serine-rich protein 1 [PF15160.8, score=70.7]} {Human: ENSG00000249481, SPATS1, spermatogenesis associated serine rich 1, [RH, Score=73.9, Expect=1e-14]} {Mouse: ENSMUSG00000023935, Spats1, spermatogenesis associated, serine-rich 1, [RH, Score=72.8, Expect=3e-14]} {Smed: dd_Smed_v6_8305_0_1, dd_Smed_v6_8305_0_1, [RH, Score=211, Expect=3e-68]} {RNA1509_15481} {RNA1310_26555} {RNA815_13979} |
12. | MligTC455_24612 | 12 | 0.25 | Mlig455_000425, Mlig455_000489, Mlig455_000526, Mlig455_024858 | Neo: - Age: - |
SCN1A | 0.963 | - | - | - | - | 0.963 | - | Mlig455_000425 {REF} {Length: 2186} {Pfam: Ion transport protein [PF00520.33, score=296.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.9]; Polycystin cation channel [PF08016.14, score=23.2]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=502, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=498, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=490, Expect=7e-153]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=486, Expect=2e-151]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=486, Expect=9e-152]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=481, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=481, Expect=4e-150]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=500, Expect=7e-157]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=494, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=490, Expect=4e-153]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=484, Expect=2e-151]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=484, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=483, Expect=1e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=481, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=475, Expect=6e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=538, Expect=2e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=189, Expect=6e-50]} {Smed: dd_Smed_v6_13973_0_1, dd_Smed_v6_13973_0_1, [Score=610, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000489 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=23.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=504, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=9e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=1e-151]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=483, Expect=9e-150]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=482, Expect=8e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=479, Expect=4e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=2e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=1e-150]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=483, Expect=6e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=5e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=627, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000526 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.7]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=22.9]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=503, Expect=3e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=8e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=8e-152]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=484, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=483, Expect=6e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=478, Expect=5e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=3e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=2e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=484, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=6e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=628, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_024858 {REF} {Length: 1954} {Pfam: Ion transport protein [PF00520.33, score=318.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=32.1]; Polycystin cation channel [PF08016.14, score=30.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=660, Expect=0.0]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=654, Expect=0.0]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=649, Expect=0.0]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=640, Expect=0.0]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=639, Expect=0.0]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=635, Expect=0.0]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=631, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=627, Expect=0.0]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=655, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=652, Expect=0.0]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=646, Expect=0.0]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=645, Expect=0.0]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=637, Expect=0.0]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=635, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=630, Expect=0.0]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=623, Expect=0.0]} {Dmel: FBgn0285944, para, paralytic, [Score=701, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=268, Expect=3e-77]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=816, Expect=0.0]} {RNA1310_51142} |
13. | MligTC455_33332 | 15 | 0.32 | Mlig455_050529 | Neo: - Age: - |
TLR4 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_050529 {REF} {Length: 5807} {Pfam: Leucine rich repeat [PF13855.8, score=88.8]; Leucine Rich repeats (2 copies) [PF12799.9, score=65.7]; TIR domain [PF01582.22, score=26.4]; Leucine Rich Repeat [PF00560.35, score=23.4]; TIR domain [PF13676.8, score=21.7]} {Human: ENSG00000136869, TLR4, toll like receptor 4, [Score=83.2, Expect=1e-15]} {Mouse: ENSMUSG00000030600, Lrfn1, leucine rich repeat and fibronectin type III domain containing 1, [Score=72.0, Expect=2e-12]} {Dmel: FBgn0026760, Tehao, [Score=79.7, Expect=6e-15]} {Celegans: WBGene00004854, slt-1, Slit homolog 1 protein, [Score=53.1, Expect=8e-07]} {RNA1310_135658} {RNA815_11474} |
14. | MligTC455_11279 | 35 | 0.73 | Mlig455_013960 | Neo: - Age: - |
ANK1 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_013960 {REF} {Length: 3851} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=175.9]; Ankyrin repeats (many copies) [PF13637.8, score=158.1]; Ankyrin repeats (many copies) [PF13857.8, score=137.2]; Ankyrin repeat [PF00023.32, score=134.2]; Ankyrin repeat [PF13606.8, score=115.0]; Mab-21 protein [PF03281.16, score=28.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=171, Expect=9e-43]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=168, Expect=7e-42]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=173, Expect=1e-43]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=192, Expect=1e-49]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=162, Expect=2e-40]} {Smed: dd_Smed_v6_2072_0_2, dd_Smed_v6_2072_0_2, [Score=150, Expect=9e-37]} |
15. | MligTC455_51666 | 8 | 0.17 | Mlig455_048609 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_048609 {REF} {Length: 1581} {NoTransDecoderORF} {RNA1310_79624} | |
16. | MligTC455_51667 | 8 | 0.16 | Mlig455_048719 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_048719 {REF} {Length: 1694} {NoTransDecoderORF} {RNA1310_79624} | |
17. | MligTC455_18778 | 13 | 0.27 | Mlig455_049126 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_049126 {REF} {Length: 424} {RNA1310_131459} |